BARICORDI, Olavio
 Distribuzione geografica
Continente #
NA - Nord America 12.151
AS - Asia 6.724
EU - Europa 6.087
SA - Sud America 954
Continente sconosciuto - Info sul continente non disponibili 185
AF - Africa 143
OC - Oceania 15
Totale 26.259
Nazione #
US - Stati Uniti d'America 11.864
IT - Italia 2.826
SG - Singapore 2.348
CN - Cina 2.070
DE - Germania 815
BR - Brasile 745
UA - Ucraina 729
VN - Vietnam 673
HK - Hong Kong 498
TR - Turchia 381
GB - Regno Unito 361
FI - Finlandia 337
FR - Francia 232
RU - Federazione Russa 190
JP - Giappone 154
CA - Canada 145
IN - India 141
SE - Svezia 137
BD - Bangladesh 120
NL - Olanda 116
PL - Polonia 114
MX - Messico 87
AR - Argentina 62
IQ - Iraq 50
ZA - Sudafrica 50
ID - Indonesia 49
AT - Austria 42
EC - Ecuador 39
CO - Colombia 35
ES - Italia 34
TH - Thailandia 30
BE - Belgio 29
UZ - Uzbekistan 28
MA - Marocco 26
PK - Pakistan 26
VE - Venezuela 22
PH - Filippine 21
LT - Lituania 19
CH - Svizzera 18
SA - Arabia Saudita 18
CL - Cile 16
CZ - Repubblica Ceca 16
MY - Malesia 16
CR - Costa Rica 14
IR - Iran 14
AE - Emirati Arabi Uniti 13
AU - Australia 13
EG - Egitto 13
IE - Irlanda 13
KE - Kenya 11
PE - Perù 11
PY - Paraguay 10
JM - Giamaica 9
RO - Romania 9
IL - Israele 8
KZ - Kazakistan 8
MD - Moldavia 8
TN - Tunisia 8
AZ - Azerbaigian 7
BO - Bolivia 7
LB - Libano 7
OM - Oman 7
AL - Albania 6
ET - Etiopia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
JO - Giordania 5
KR - Corea 5
NG - Nigeria 5
NO - Norvegia 5
PT - Portogallo 5
BB - Barbados 4
BG - Bulgaria 4
HN - Honduras 4
NI - Nicaragua 4
NP - Nepal 4
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
AO - Angola 2
BH - Bahrain 2
BJ - Benin 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
Totale 26.058
Città #
Singapore 1.480
Ashburn 1.136
Woodbridge 1.029
Fairfield 917
San Jose 849
Jacksonville 715
Chandler 713
Houston 656
Beijing 572
Santa Clara 529
Hong Kong 490
Wilmington 377
Ann Arbor 375
Seattle 367
Hangzhou 325
Milan 308
Cambridge 292
New York 279
Ho Chi Minh City 240
Rome 236
Izmir 213
Munich 209
Los Angeles 190
Nanjing 189
Dallas 174
Council Bluffs 152
Tokyo 149
Princeton 146
Helsinki 136
Hanoi 131
Boardman 123
Lauterbourg 113
Warsaw 103
Addison 99
Shenyang 83
São Paulo 83
San Diego 79
The Dalles 72
Mexico City 70
Shanghai 70
Toronto 67
Buffalo 65
Dearborn 63
Orem 63
Nanchang 62
Bologna 58
Naples 58
Ferrara 54
Turku 53
Hebei 52
Turin 52
Hefei 45
Chennai 43
Changsha 42
Tianjin 41
Bremen 40
Falkenstein 40
Brooklyn 39
London 39
Montreal 37
Verona 37
Bari 35
Florence 35
Vienna 35
Denver 34
Frankfurt am Main 34
Jiaxing 34
Falls Church 33
Haiphong 32
Norwalk 30
San Mateo 30
Palermo 29
Chicago 28
Da Nang 28
Kunming 27
Rio de Janeiro 27
Bangkok 26
Johannesburg 26
Manchester 26
Mountain View 26
Stockholm 26
Tashkent 25
Brussels 24
Baghdad 23
Moscow 23
Redwood City 23
Amsterdam 22
Atlanta 22
Mumbai 22
Philadelphia 22
Augusta 21
Brescia 20
Jinan 19
Boston 18
Guangzhou 18
Phoenix 18
Zhengzhou 18
Modena 17
Hải Dương 16
Padova 16
Totale 16.507
Nome #
Mutazione Q283P nel gene HFE in un eterozigote C282Y affetto da emocromatosi. 1.696
Associazione tra il polimorfismo c.1298A>C del gene MTHFR (Metilenetetraidrofolato Reduttasi) e l’artrite reumatoide 1.332
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 425
Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis 422
HLA-G molecules are constitutively expressed by synovial fibroblasts and up-modulated in osteoarthritis 324
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 302
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 257
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 256
Enhanced P2X7 activity in human fibroblasts from diabetic patients: a possible pathogenetic mechanism for vascular damage in diabetes 253
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 250
An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes 244
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 244
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 243
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 237
Association between toluene diisocyanate-induced asthma and DQB1 markers: a possible role for aspartic acid at position 57 236
Emerging topics and new perspectives on HLA-G 230
The antibiotic polymyxin B modulates P2X7 receptor function 221
Analisi del polimorfismo IVS2+4T>C del gene HFE in soggetti con sovraccarico di ferro. 219
Cotransplantation of mesenchymal cells and a higher relapse rate: a role for HLA-G molecules? 218
Purinoceptor function in the immune system 216
A novel mutation of HFE explains the classical phenotype of hereditary hemochromatosis in a C282Y carrier 216
Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease 215
Reduced production of anti-inflammatory soluble HLA-G molecules in styrene exposed workers 215
HLA-G expression is a fundamental prerequisite to pregnancy 212
Antigenes sHLA-G et polypose naso-sinusienne. 209
The antibiotic polymyxin B modulates P2X7 receptor function 206
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 203
Increased sensitivity of DMD lymphoblastoid cell to low doses of X irradiation 200
Antigeni HLA e livelli sierici di HLA solubile nella malattia di Meniere 199
CYTOLYTIC P2X PURINOCEPTORS 198
The c.1298A>C polymorphism in the Methylenetetrahydrofolate Reductase (MTHFR) gene is risk factor for Rheumatoid Arthritis 196
In vitro studies during long-term oral administration of specific transfer factor 191
Basal production of soluble HLA-G molecules by peripheral blood monocytes in patients with diisocyanate-induced asthma. 190
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 185
Anti HLA class I monoclonal antibody effect on PKC kinetics in PHA activated human peripheral blood mononuclear and E+ cells 185
Isolation of stem cell populations with trophic and immunoregulatory functions from human intestinal tissues: potential for cell therapy in inflammatory bowel disease 185
Soluble HLA-G molecules in follicular fluid: a tool for oocyte selection in IVF? 184
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 184
Human leukocyte antigen-A, -B, -C and -DR alleles and soluble human leukocyte antigen class I serum level in Meniere's disease. 180
Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in Ulcerative Colitis and Crohn's disease: a non invasive diagnostic tools? 180
Role of protein kinase C in the phosphatidylserine-induced inhibition of DNA synthesis in blood mononuclear cells 179
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Report II 178
The HLA-G genotype is associated with IL-10 levels in activated PBMCs 176
Responses to extracellular ATP of lymphoblastoid cell lines from Duchenne muscular dystrophy patients 175
Therapy modifies HLA-G secretion differently in Crohn's disease and ulcerative colitis patients. 175
HLA B51 antigen associated with neutrophil hyper-reactivity 175
Utilizzo delle MSCs nel controllo del rigetto dei trapianti 175
Programmable interactions of functionalized single bioparticles in a dielectrophoresis-based microarray chip. 174
Allergic women have reduced sHLA-G plasma levels at delivery 173
Extarcellular ATP triggers IL-1beta release by activating the purinergic P2Z receptor of human macrophages 173
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 173
Comment on "Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: Generation of IL-10 and induction of regulatory T cells" 172
Allogeneic gene-modified tumour cells in metastatic kidney cancer. Preliminary report 172
An anti-HLA class I monoclonal antibody alters the progression in the cell cycle of phytohemagglutinin-activated human T lymphocytes 172
P2 purinoceptors in the immune system 171
Farmacogenetica dei taxani nel trattamento del carcinoma mammario: possibile ruolo nell’identificazione del rischio di tossicità. 171
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 170
A ryanodine receptor-like Ca2+ channel is expressed in nonexcitable cells 168
New insights into HLA-G and inflammatory diseases 166
Analisi dei genotipi ed aplotipi HFE nella popolazione Ferrarese 165
Increased production of soluble HLA-G molecules in stimulated peripheral blood mononuclear cells following extracorporeal photopheresis. Is it a mechanism involved in the therapeutic effect of the procedure? 164
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico, trattamenti e malattia. 164
MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region 164
Production of sHLA-G molecules by “in vitro” matured cumulus-oocyte complex 163
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma. 163
Polymorphism in the 5' upstream regulatory and 3' untranslated regions of the HLA-G gene in relation to soluble HLA-G and IL-10 expression 162
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy 162
The c.1298A>C polymorphism in the methylenetetrahydrofolate reductase gene is associated with rheumatoid arthritis susceptibility in Italian patients 161
Concentrazione di HLA-G solubile e interleuchina 10 nel plasma di pazienti psoriasici: possibile correlazione tra stato immunitario sistemico e malattia. 160
Association between MTHFR C.1298A > C polymorphism in the methylene-tetrahydrofolate (MTHFR) gene and increased risk for rheumatoid arthritis 159
Ruolo farmacogenetico del polimorfismo HLA-G 14bp nella risposta alla terapia con Methotrexate nell’artrite reumatoide. 159
Frequenze genotipiche ed aplotipiche HFE nella popolazione della Provincia di Ferrara 158
Transfer factor in chronic mucocutaneous candidiasis 158
P2X7: a novel growth-stimulating receptor in B lymphoblastoid cells 157
Increased proliferation rate of lymphoid cells transfected with the P2X7 ATP receptor 156
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: A role for HLA-G molecules 156
Associazione tra HLA-G e Lupus Eritematoso Sistemico. 153
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 151
Nucleotide receptor: an emerging family of regulatory molecules in blood cells 150
Soluble Human Leukocyte Antigen-G and Its Insertion/Deletion Polymorphism in Papillary Thyroid Carcinoma: Novel Potential Biomarkers of Disease? 149
Ruolo dell’HLA-G nel mantenimento del privilegio immune dell’occhio. 146
Soluble HLA-G and IL-10 production in occupational and nonoccupational asthma 145
Mouse dendritic cells express the P2X7 purinergic receptor: Characterization and possible participation in antigen presentation 144
Antibody-antigen interactions in dielectrophoresis buffers for cell manipulation on dielectrophoresis-based Lab-on-chip devices. 144
CSF levels of soluble classical HLA-I and non-classical HLA-G molecules in relapsing-remitting multiple sclerosis and their association with CSF IL-10 concentrations and MRI findings. 144
Programmable binding of single microspheres to single target tumor cells using a dielectrophoresis (DEP) based “lab-on-a-chip” array. 144
A simple method to identify bone marrow mesenchymal stromal cells with a high immunosuppressive potential 144
Human leukocyyte antigen associations in occupational asthma induced by isocyanates 141
Il ruolo del polimorfismo HLA-G 14bp nell'invecchiamento. 140
Implication of immunosoppressive molecules during human oocyte maturation 139
Presenza di molecole solubili HLA-G nel plasma da cordone ombelicale: un possibile marcatore di tolerogenicità? 134
Can HLA-G predict disease course in rheumatoid arthritis patients? 134
Potential role of soluble HLA-G molecules in multiple sclerosis 133
Serological and molecular HLA typing in Italian Behcet's patients: significant association to B51-DR5-DQw3 haplotype 131
In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment 130
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 129
The possible role of HLA-G molecules in human oocyte/embryo secretome 129
HLA-G expression and regulation in early embryos 127
Ruolo biologico dell'HLA-G solubile nella gravidanza. 126
Una nuova mutazione del gene HFE in un eterozigote C282Y con emocromatosi. 123
Totale 21.107
Categoria #
all - tutte 103.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 680
Totale 104.169


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.636 0 206 101 86 65 60 79 85 69 134 152 599
2022/20231.873 160 122 67 222 310 251 94 208 204 53 114 68
2023/20241.418 90 141 91 47 106 264 75 79 72 101 92 260
2024/20253.823 170 184 294 208 456 325 186 208 572 378 483 359
2025/20268.578 882 430 724 1.075 1.240 601 1.023 417 788 918 336 144
2026/2027465 212 253 0 0 0 0 0 0 0 0 0 0
Totale 26.259